Additionally, retatrutide significantly improved blood lipids and blood pressure compared to placebo
We discount these services for our GLP program patients
Results revealed that gastrointestinal symptoms such as nausea, vomiting, and abdominal discomfort, which were dose-dependent and mainly mild in severity, were the side effects of LY3437943
While its still in research, its early data offers hope for patients struggling with obesity, diabetes, and metabolic dysfunction
[DOI] [PMC free article] [PubMed] [Google Scholar] Associated Data This section collects any data citations, data availability statements, or supplementary materials included in this article.
This can make stomach-related symptoms more noticeable at first, especially in the early weeks or after a dose increase